Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging

被引:83
作者
Lu, Guan-Hua [1 ,2 ,3 ]
Shang, Wen-Ting [2 ]
Deng, Han [1 ,2 ]
Han, Zi-Yu [1 ,2 ]
Hu, Min [1 ,2 ]
Liang, Xiao-Yuan [1 ]
Fang, Chi-Hua [1 ]
Zhu, Xin-Hong [3 ]
Fan, Ying-Fang [1 ]
Tian, Jie [2 ,4 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou 510280, Guangdong, Peoples R China
[2] Inst Automat, CAS Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China
[3] Southern Med Univ, Dept Neurobiol, Guangzhou 510515, Guangdong, Peoples R China
[4] Beihang Univ, Beijing 100083, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Photothermal therapy; Single-walled carbon nanotubes; Imaging; Pancreatic cancer; IGF-1R; GROWTH; GEMCITABINE; GUIDANCE; STROMA; AGENTS; DYE;
D O I
10.1016/j.biomaterials.2018.12.025
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Pancreatic cancer is one of the most lethal malignancies worldwide. The existing therapeutic regimen in the clinic for advanced inoperable carcinomas are far from satisfactory, thus it is urgent to seek more effective anticancer strategies. In the pursuit of novel, more effective interventions, photothermal therapy (PTT) based on nanomaterials has attracted increased attention, Recent advances in related fields have catalyzed the generation of novel nanoprobes, such as organic dyes, metal nanoparticles. However, organic dyes are poorly stable and easy to quench while metal nanoparticles with potential metal toxicity are difficult to degrade, both of which have low light-to-heat conversion efficiency, broad spectrum of anti-tumor effects, and lack of tumor targeting specificity. Single-walled carbon nanotubes (SWNTs) can remedy the above inadequacies. Herein, we report our water-soluble, bio-stable and low-toxicity SWNTs with excellent photothermal conversion efficiency. Specific modifications can enable visualization of the aggregate characteristics of SWNTs at the macroscopic or microscopic level in tumors. The dye-conjugated SWNTs bound with targeting antibodies that can induce them specifically targeting to pancreatic tumors for purposes of performing dyes imaging-guided cytotoxic PTT. PTT using this method achieves precise and excellent curative effects with minimal adverse effects, thus providing a promising strategy for anticancer therapy.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 53 条
  • [1] Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
    Adiseshaiah, Pavan P.
    Crist, Rachael M.
    Hook, Sara S.
    McNeil, Scott E.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (12) : 750 - 765
  • [2] Surface-Charge-Dependent Cell Localization and Cytotoxicity of Cerium Oxide Nanoparticles
    Asati, Atul
    Santra, Santimukul
    Kaittanis, Charalambos
    Perez, J. Manuel
    [J]. ACS NANO, 2010, 4 (09) : 5321 - 5331
  • [3] Advancement in carbon nanotubes: basics, biomedical applications and toxicity
    Beg, Sarwar
    Rizwan, Mohammad
    Sheikh, Asif M.
    Hasnain, M. Saquib
    Anwer, Khalid
    Kohli, Kanchan
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (02) : 141 - 163
  • [4] Bacterial magnetic nanoparticles for photothermal therapy of cancer under the guidance of MRI
    Chen, Chuanfang
    Wang, Shunhao
    Li, Linlin
    Wang, Pingping
    Chen, Changyou
    Sun, Zhaoyu
    Song, Tao
    [J]. BIOMATERIALS, 2016, 104 : 352 - 360
  • [5] Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
    Chiorean, Elena Gabriela
    Coveler, Andrew L.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3529 - 3545
  • [6] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Bouche, Olivier
    Guimbaud, Rosine
    Becouarn, Yves
    Adenis, Antoine
    Raoul, Jean-Luc
    Gourgou-Bourgade, Sophie
    de la Fouchardiere, Christelle
    Bennouna, Jaafar
    Bachet, Jean-Baptiste
    Khemissa-Akouz, Faiza
    Pere-Verge, Denis
    Delbaldo, Catherine
    Assenat, Eric
    Chauffert, Bruno
    Michel, Pierre
    Montoto-Grillot, Christine
    Ducreux, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1817 - 1825
  • [7] Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
    Cunningham, David
    Chau, Ian
    Stocken, Deborah D.
    Valle, Juan W.
    Smith, David
    Steward, William
    Harper, Peter G.
    Dunn, Janet
    Tudur-Smith, Catrin
    West, Julia
    Falk, Stephen
    Crellin, Adrian
    Adab, Fawzi
    Thompson, Joyce
    Leonard, Pauline
    Ostrowski, Joe
    Eatock, Martin
    Scheithauer, Werner
    Herrmann, Richard
    Neoptolemos, John P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5513 - 5518
  • [8] Family of Enhanced Photoacoustic Imaging Agents for High-Sensitivity and Multiplexing Studies in Living Mice
    de la Zerda, Adam
    Bodapati, Sunil
    Teed, Robert
    May, Salomon Y.
    Tabakman, Scott M.
    Liu, Zhuang
    Khuri-Yakub, Butrus T.
    Chen, Xiaoyuan
    Dai, Hongjie
    Gambhir, Sanjiv S.
    [J]. ACS NANO, 2012, 6 (06) : 4694 - 4701
  • [9] The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
    Erkan, Mert
    Hausmann, Simone
    Michalski, Christoph W.
    Fingerle, Alexander A.
    Dobritz, Martin
    Kleeff, Joerg
    Friess, Helmut
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) : 454 - 467
  • [10] The current status of IGF-I assays - A 2009 update
    Frystyk, Jan
    Freda, Pamela
    Clemmons, David R.
    [J]. GROWTH HORMONE & IGF RESEARCH, 2010, 20 (01) : 8 - 18